Gregory S. Basarab

2.2k citations

61 papers · 1.4k indexed · h-index 23

Impact in

Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria

Papers in

Molecular Medicine 8
- Antibiotic Resistance in Bacteria 8
Toxicology 5
- Bioactive Compounds and Antitumor Agents 5

Co-authors: Douglas B. Jordan Z. Wawrzak T. Lundqvist Ylva Lindqvist C. Nicholas Hodge John P. Pierce James Chen Simon L. Xu
Journals: Journal of Medicinal Chemistry (11 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)Biochemistry (6 papers)ACS Infectious Diseases (5 papers)Antimicrobial Agents and Chemotherapy (3 papers)
Partner nations: United States South Africa United Kingdom

In The Last Decade

Gregory S. Basarab

60 papers receiving 1.4k citations

Peers

Countries citing papers authored by Gregory S. Basarab

Since Specialization

Citations

This map shows the geographic impact of Gregory S. Basarab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory S. Basarab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory S. Basarab more than expected).

Fields of papers citing papers by Gregory S. Basarab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory S. Basarab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory S. Basarab. The network helps show where Gregory S. Basarab may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gregory S. Basarab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory S. Basarab Line = papers co-authored together Gregory S. Basarab links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C–Domain-Selective/Neprilysin Inhibitors Journal of Medicinal Chemistry ·Gyles E. Cozier, Trufka Dimitrova, Charles J. Eyermann, Gregory S. Basarab, Sylva L. U. Schwager, Kelly Chibale, Edward D. Sturrock, K. Ravi Acharya	2025	0
2	Cell-Based Progression of Spiroindoline Phenotypic Hits Leads to the Identification of Compounds with Diverging Parasitological Profiles against the Human Malaria Parasite Plasmodium falciparum Journal of Medicinal Chemistry ·Cheri Hugo, Julio Andrés Beltrán Cobo, 和夫藤川, L Houssin-Bailly, Claire Le Manach, رشا صالح, Dale Taylor, 崇中井, Mathew Njoroge, Nina Lawrence, Christel Brunschwig, 荊木美行, Brian J. Cox, Sergio Wittlin, Thomas W von Geldern, Dennis A. Smith, James Duffy, Gregory S. Basarab, Kelly Chibale	2025	1
3	A Water‐Soluble Polymer‐Lumefantrine Conjugate for the Intravenous Treatment of Severe Malaria Macromolecular Bioscience ·Hinata Aoki, Krishnkumarsinh Sur, Fengyou He, 高婷梅, P. Delacour, Lynne A. Pilcher, Ibukun M. Famuyide, Lyndy J. McGaw, Dale Taylor, Liezl Gibhard, Gregory S. Basarab, Mohammed O. Balogun	2023	1
4	Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria European Journal of Medicinal Chemistry ·Soo Yei Ho, Weiling Wang, Fui Mee Ng, Jennifer Croft, Antoine Tresgots, Emmarica Houlder, Shi Hua Ang, Si Si Liew, P. Boydell, Yvonne Tze Fung Tan, Anders Poulsen, Vishal Pendharkar, Kanda Sangthongpitag, John I. Manchester, Gregory S. Basarab, Jeffrey Hill, Thomas H. Keller, Joseph Cherian	2018	11
5	Absorption, distribution, metabolism and elimination of 14C-ETX0914, a novel inhibitor of bacterial type-II topoisomerases in rodents Xenobiotica ·Jian Guo, Camil Joubran, Pedro Alvarado-Sosa, Gregory S. Basarab, Scott Grimm, Karthick Vishwanathan	2016	7
6	Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome Proceedings of the National Academy of Sciences ·N.B. Olivier, Russ B. Altman, J. Noeske, Gregory S. Basarab, Erin Code, Andrew D. Ferguson, Ning Gao, Jian Huang, Manuel F. Juette, Stephania Livchak, M.D. Miller, D. Bryan Prince, J.H.D. Cate, Ed T. Buurman, Scott C. Blanchard	2014	33
7	In vitroandin vivometabolism of¹⁴C-AZ11, a novel inhibitor of bacterial DNA gyrase/type II topoisomerase Xenobiotica ·Jian Guo, Camil Joubran, Pedro Alvarado-Sosa, Fei Zhou, Gregory S. Basarab, Karthick Vishwanathan	2014	3
8	Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: Incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabilty Bioorganic & Medicinal Chemistry Letters ·Gregory S. Basarab, Pamela Hill, Charles J. Eyermann, Thomas Wood, Helena Käck, Moe Latt	2012	13
9	Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: A novel pro-drug approach to increase exposure Bioorganic & Medicinal Chemistry Letters ·Gregory S. Basarab, Pamela Hill, 王建君, Peter J. H. Webborn	2008	28
10	Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): Pyridodiazepine amines Bioorganic & Medicinal Chemistry Letters ·Bolin Geng, Gregory S. Basarab, Janelle Comita-Prevoir, Madhusudhan Gowravaram, Pamela Hill, Andrew F. Kiely, James T. Loch, Lawrence MacPherson, Marshall Morningstar, G. B. MULLEN, Márta Fekete, Alexander L. Satz, Charles J. Eyermann, T. Lundqvist	2008	39
11	Design of Inhibitors of Scytalone Dehydratase: Probing Interactions with an Asparagine Carboxamide Bioorganic & Medicinal Chemistry ·Gregory S. Basarab, Douglas B. Jordan, GRETA DEPLEDGE, Rand S. Schwartz	2002	7
12	Structures of Trihydroxynaphthalene Reductase-Fungicide Complexes Structure ·Shuang Bai Shuang Bai, Gregory S. Basarab, Anthony A. Gatenby, Barbara Valent, Douglas B. Jordan	2001	32
13	Selection of a potent inhibitor of trihydroxynaphthalene reductase by sorting disease control data Bioorganic & Medicinal Chemistry Letters ·Shuang Bai Shuang Bai, Gregory S. Basarab, Anthony A. Gatenby, Douglas B. Jordan	2000	5
14	Cyclobutane carboxamide inhibitors of fungal melanin: biosynthesis and their evaluation as fungicides Bioorganic & Medicinal Chemistry ·Lee D. Jennings, Dennis R. Rayner, Douglas B. Jordan, 井上義章, Gregory S. Basarab, 陆洪非, 通弘新島, John K. Lee, Rand S. Schwartz, Shunyao Ma	2000	27
15	High-resolution structures of scytalone dehydratase-inhibitor complexes crystallized at physiological pH Proteins Structure Function and Bioinformatics ·Z. Wawrzak, Tatyana Sandalova, James J. Steffens, Gregory S. Basarab, T. Lundqvist, Ylva Lindqvist, Douglas B. Jordan	1999	31
16	Wild-Type Enzyme as a Reporter of Inhibitor Binding by Catalytically Impaired Mutant Enzymes Biochemical and Biophysical Research Communications ·Gregory S. Basarab, Douglas B. Jordan	1999	1
17	Design of scytalone dehydratase inhibitors as rice blast fungicides: Derivatives of norephedrine Bioorganic & Medicinal Chemistry Letters ·Gregory S. Basarab, Douglas B. Jordan, GRETA DEPLEDGE, Rand S. Schwartz, Z. Wawrzak	1999	24
18	Phytoene desaturase. A model for the optimization of inhibitors. G. H. Mitchell, Don R. Baker, Auflage Mit, Gregory S. Basarab	1995	2
19	Crystal structure of scytalone dehydratase — a disease determinant of the rice pathogen, Magnaporthe grisea Structure ·T. Lundqvist, Janet Rice, C. Nicholas Hodge, Gregory S. Basarab, John P. Pierce, Ylva Lindqvist	1994	116
20	Design of Sterol Reductase Inhibitors. Insights into the Binding Conformation of Tertiary Amine Fungicides. Gregory S. Basarab, Robert S. Livingston, Steven J. Vollmer, 陈会清, Su Hong Min	1992	1

About Gregory S. Basarab

Gregory S. Basarab is a scholar working on Molecular Medicine, Toxicology, Organic Chemistry, Molecular Biology and Pharmacology, having authored 61 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (16 papers), Biochemical and Molecular Research (11 papers), Fungal Plant Pathogen Control (10 papers), Antibiotic Resistance in Bacteria (8 papers), Enzyme Structure and Function (7 papers), Bioactive Compounds and Antitumor Agents (5 papers), Synthesis and biological activity (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). The work is most often cited by research in Toxicology (120 citations), Molecular Medicine (159 citations), Organic Chemistry (432 citations), Pharmacology (211 citations) and Molecular Biology (835 citations). Gregory S. Basarab has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Douglas B. Jordan, Z. Wawrzak, T. Lundqvist, Ylva Lindqvist, C. Nicholas Hodge, John P. Pierce, James Chen, Simon L. Xu, Pamela Hill and Rand S. Schwartz. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Biochemistry, ACS Infectious Diseases and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact